{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:41:17Z","timestamp":1792687277397,"version":"4.5.0"},"reference-count":28,"publisher":"MyJove Corporation","issue":"99","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/52655","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T20:00:07Z","timestamp":1430942407000},"source":"Crossref","is-referenced-by-count":1,"title":["Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches"],"prefix":"10.3791","author":[{"given":"Linlin","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitra L.","family":"Farrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Krendelchtchikov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiana L.","family":"Matthews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2015,5,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1128\/jvi.66.11.6721-6727.1992","type":"journal-article","article-title":"Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutant","volume":"66","author":"Cheng","year":"1992","unstructured":"Cheng, S. M., et al. Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutant. Journal of virology. 66, 6721-6727 (1992).","journal-title":"Journal of virology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e11815","DOI":"10.1371\/journal.pone.0011815","type":"journal-article","article-title":"HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach","volume":"5","author":"Matthews","year":"2010","unstructured":"Matthews, Q. L., et al. HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach. PloS one. 5, e11815 (2010).","journal-title":"PloS one"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1128\/jvi.71.7.5330-5335.1997","type":"journal-article","article-title":"Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression","volume":"71","author":"DeMatteo","year":"1997","unstructured":"DeMatteo, R. P., et al. Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression. Journal of virology. 71, 5330-5335 (1997).","journal-title":"Journal of virology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1743-422X-11-112","type":"journal-article","article-title":"A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the 'Antigen Capsid-Incorporation' strategy","volume":"11","author":"Gu","year":"2014","unstructured":"Gu, L., et al. A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the 'Antigen Capsid-Incorporation' strategy. Virology journal. 11, 112 (2014).","journal-title":"Virology journal"},{"key":"ref5","type":"journal-article","article-title":"Viral Vectors for Vaccine Development","author":"Matthews","year":"2013","unstructured":"Matthews, Q. L., Krendelchtchikov, A. L. G., Li, Z. C. Viral Vectors for Vaccine Development. INTECH. (2013).","journal-title":"INTECH"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/erv.09.1","type":"journal-article","article-title":"Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines","volume":"8","author":"Tang","year":"2009","unstructured":"Tang, D. C., Zhang, J., Toro, H., Shi, Z., Van Kampen, K. R. Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines. Expert review of vaccines. 8, 469-481 (2009).","journal-title":"Expert review of vaccines"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e61571","DOI":"10.1371\/journal.pone.0061571","type":"journal-article","article-title":"An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5","volume":"8","author":"Flatt","year":"2013","unstructured":"Flatt, J. W., Kim, R., Smith, J. G., Nemerow, G. R., Stewart, P. L. An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5. PloS one. 8, e61571 (2013).","journal-title":"PloS one"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/JVI.06254-11","type":"journal-article","article-title":"Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection","volume":"86","author":"Bradley","year":"2012","unstructured":"Bradley, R. R., Lynch, D. M., Iampietro, M. J., Borducchi, E. N., Barouch, D. H. Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection. Journal of virology. 86, 625-629 (2012).","journal-title":"Journal of virology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcb.22328","type":"journal-article","article-title":"The influence of innate and pre-existing immunity on adenovirus therapy","volume":"108","author":"Zaiss","year":"2009","unstructured":"Zaiss, A. K., Machado, H. B., Herschman, H. R. The influence of innate and pre-existing immunity on adenovirus therapy. Journal of cellular biochemistry. 108, 778-790 (2009).","journal-title":"Journal of cellular biochemistry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/JVI.78.6.2666-2673.2004","type":"journal-article","article-title":"Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors","volume":"78","author":"Sumida","year":"2004","unstructured":"Sumida, S. M., et al. Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors. Journal of virology. 78, 2666-2673 (2004).","journal-title":"Journal of virology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","type":"journal-article","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein","volume":"174","author":"Sumida","year":"2005","unstructured":"Sumida, S. M., et al. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. Journal of immunology. 174, 7179-7185 (2005).","journal-title":"Journal of immunology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.06165-11","type":"journal-article","article-title":"Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions","volume":"86","author":"Bradley","year":"2012","unstructured":"Bradley, R. R., et al. Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions. Journal of virology. 86, 1267-1272 (2012).","journal-title":"Journal of virology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.72.3.2388-2397.1998","type":"journal-article","article-title":"Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity","volume":"72","author":"Gahery-Segard","year":"1998","unstructured":"Gahery-Segard, H., et al. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. Journal of virology. 72, 2388-2397 (1998).","journal-title":"Journal of virology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e60347","DOI":"10.1371\/journal.pone.0060347","type":"journal-article","article-title":"Using multivalent adenoviral vectors for HIV vaccination","volume":"8","author":"Gu","year":"2013","unstructured":"Gu, L., et al. Using multivalent adenoviral vectors for HIV vaccination. PloS one. 8, e60347 (2013).","journal-title":"PloS one"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e41381","DOI":"10.1371\/journal.pone.0041381","type":"journal-article","article-title":"Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon","volume":"7","author":"Tian","year":"2012","unstructured":"Tian, X., et al. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon. PloS one. 7, e41381 (2012).","journal-title":"PloS one"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"12775","DOI":"10.1128\/JVI.76.24.12775-12782.2002","type":"journal-article","article-title":"Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon","volume":"76","author":"Wu","year":"2002","unstructured":"Wu, H., et al. Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon. Journal of virology. 76, 12775-12782 (2002).","journal-title":"Journal of virology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1128\/JVI.79.6.3382-3390.2005","type":"journal-article","article-title":"Identification of sites in adenovirus hexon for foreign peptide incorporation","volume":"79","author":"Wu","year":"2005","unstructured":"Wu, H., et al. Identification of sites in adenovirus hexon for foreign peptide incorporation. Journal of virology. 79, 3382-3390 (2005).","journal-title":"Journal of virology"},{"key":"ref18","first-page":"7964","type":"journal-article","article-title":"Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions","volume":"86","author":"Qiu","year":"2012","unstructured":"Qiu, H., et al. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions. Journal of. 86, 7964-7975 (2012).","journal-title":"Journal of"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"10906","DOI":"10.1128\/JVI.75.22.10906-10911.2001","type":"journal-article","article-title":"Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5","volume":"75","author":"Parker","year":"2001","unstructured":"Parker, C. E., et al. Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5. Journal of virology. 75, 10906-10911 (2001).","journal-title":"Journal of virology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e3089","DOI":"10.1371\/journal.pntd.0003089","type":"journal-article","article-title":"Immunization with Hexon Modified Adenoviral Vectors Integrated with gp83 Epitope Provides Protection against Trypanosoma cruzi Infection","volume":"8","author":"Farrow","year":"2014","unstructured":"Farrow, A. L., et al. Immunization with Hexon Modified Adenoviral Vectors Integrated with gp83 Epitope Provides Protection against Trypanosoma cruzi Infection. PLoS neglected tropical diseases. 8, e3089 (2014).","journal-title":"PLoS neglected tropical diseases"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1128\/JVI.02667-05","type":"journal-article","article-title":"Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity","volume":"80","author":"Krause","year":"2006","unstructured":"Krause, A., et al. Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity. Journal of virology. 80, 5523-5530 (2006).","journal-title":"Journal of virology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(02)00237-9","type":"journal-article","article-title":"Modification of a fiber protein in an adenovirus vector improves in vitro gene transfer efficiency to the mouse microglial cell line","volume":"324","author":"Omori","year":"2002","unstructured":"Omori, N., et al. Modification of a fiber protein in an adenovirus vector improves in vitro gene transfer efficiency to the mouse microglial cell line. Neuroscience letters. 324, 145-148 (2002).","journal-title":"Neuroscience letters"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1128\/JVI.76.14.6893-6899.2002","type":"journal-article","article-title":"Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX","volume":"76","author":"Dmitriev","year":"2002","unstructured":"Dmitriev, I. P., Kashentseva, E. A., Curiel, D. T. Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX. Journal of virology. 76, 6893-6899 (2002).","journal-title":"Journal of virology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virusres.2014.01.027","type":"journal-article","article-title":"Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon","volume":"183","author":"Xue","year":"2014","unstructured":"Xue, C., et al. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon. Virus research. 183, 67-74 (2014).","journal-title":"Virus research"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.virusres.2011.06.017","type":"journal-article","article-title":"Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon","volume":"160","author":"Tian","year":"2011","unstructured":"Tian, X., et al. Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon. Virus research. 160, 214-220 (2011).","journal-title":"Virus research"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e55533","DOI":"10.1371\/journal.pone.0055533","type":"journal-article","article-title":"An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer","volume":"8","author":"Kim","year":"2013","unstructured":"Kim, J. W., et al. An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer. PloS one. 8, e55533 (2013).","journal-title":"PloS one"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e1002699","DOI":"10.1371\/journal.ppat.1002699","type":"journal-article","article-title":"Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine","volume":"8","author":"Vasconcelos","year":"2012","unstructured":"Vasconcelos, J. R., et al. Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine. PLoS pathogens. 8, e1002699 (2012).","journal-title":"PLoS pathogens"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2310\/7290.2006.00029","type":"journal-article","article-title":"Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion","volume":"5","author":"Matthews","year":"2006","unstructured":"Matthews, Q. L., et al. Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion. Molecular imaging. 5, 510-519 (2006).","journal-title":"Molecular imaging"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jove.com\/video\/52655\/utilizing-antigen-capsid-incorporation-strategy-for-development","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:15:02Z","timestamp":1792685702000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/52655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,6]]},"references-count":28,"journal-issue":{"issue":"99","published-online":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.3791\/52655","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,6]]}}}